Some positive news last week when the U.S. Food and Drug Administration (FDA) approved alectinib as an adjuvant treatment for […]
Follow Us
-
+1 700 888 1234
-
Effingerstrasse 40 3008 Bern Switzerland
+1 700 888 1234
Effingerstrasse 40 3008 Bern Switzerland
Some positive news last week when the U.S. Food and Drug Administration (FDA) approved alectinib as an adjuvant treatment for […]
Bristol Myers Squibb has released a new Press Release announcing that the European Medicines Agency (EMA) has validated the marketing authorization application for repotrectinib. Repotrectinib […]
November 14th – 15th in Amsterdam We are delighted to announce that Lung Cancer Europe (LuCE) is participating in a two-day meeting […]
The ESMO Congress 2023 will take place on-site in Madrid, Spain and online in a virtual format. LuCE will be […]
About the Organization Lungunion Austria The Lungunion Austria is a patient organization (NGO and self-aid organization) for people with airway […]
consectetur adipisicing elit, sed do eiusmod tempor incididunt laboret dolore magna aliqua. Ut enim minim veniam quis nostrud exercitation ullamco laboris.
